Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Oligo and Peptide Therapeutics 2018: State of the Industry Report

ArticleImage

Download the exclusive research report now

The oligo and peptide therapeutics industry is at an interesting point. There are both potential opportunities and challenges around therapeutic discovery, clinical trials, manufacturing, delivery, regulations and business acquisitions. Informa Connect Life Sciences conducted one of the biggest surveys of its kind across professionals from pharma and biotechs, service providers, CDMOs, academia and regulators around the world.

This report based on 162 responses reveals unique insights into how industry insiders view the state of oligos and peptides in 2018; the hottest potential opportunities; the biggest challenges and how they are tackling them. To introduce the report, Dan Stanton, editor of BioProcess Insider, explores what some of the key takeaways mean for the industry.

To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.